STOCK TITAN

Xos Inc Financials

XOSWW
Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE December

This page shows Xos Inc (XOSWW) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI XOSWW FY2025

Cash turned positive in FY2025 through working-capital release, while the core operation remained a thin-margin restructuring story.

FY2025 moved from -$48.8M of operating cash burn to $5.4M of generation without an earnings turnaround. With gross margin still only 5.9% and inventory materially lower, cash improved because less money was tied up on the balance sheet, not because the business already earns much on each sale.

The biggest operating change over the last three years is cost compression: SG&A fell from $37.7M in FY2023 to $24.8M in FY2025, and R&D also stepped down. That explains why the operating loss narrowed even though revenue stayed in the same rough range, so improvement came more from resizing overhead than from a strong jump in gross profitability.

The business has at least crossed one important threshold: gross profit is now positive, after being negative in FY2023, but it is still only $2.7M against an operating loss of -$33.1M. That gap shows overhead still dominates the income statement; slightly better product economics have not yet made the company self-funding from normal operations.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 24 / 100
Financial Profile 24/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Xos Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
0

Xos Inc has an operating margin of -71.9%, meaning the company retains $-72 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is up from -82.0% the prior year.

Growth
36

Xos Inc's revenue declined 17.8% year-over-year, from $56.0M to $46.0M. This contraction results in a growth score of 36/100.

Leverage
70

Xos Inc carries a low D/E ratio of 1.59, meaning only $1.59 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 70/100, indicating a strong balance sheet with room for future borrowing.

Liquidity
38

Xos Inc's current ratio of 2.11 indicates adequate short-term liquidity, earning a score of 38/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow
0

Xos Inc's free cash flow margin of 11.7% results in a low score of 0/100. Capital expenditures of $0 absorb a large share of operating cash flow.

Returns
0

Xos Inc generates a 0.0% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100. This is up from 0.0% the prior year.

Piotroski F-Score Neutral
5/9

Xos Inc passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Mixed
-213438.74x

For every $1 of reported earnings, Xos Inc generates $-213438.74 in operating cash flow ($5.4M OCF vs -$25 net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$46.0M
YoY-17.8%
5Y CAGR+77.1%

Xos Inc generated $46.0M in revenue in fiscal year 2025. This represents a decrease of 17.8% from the prior year.

EBITDA
-$30.8M
YoY+26.0%

Xos Inc's EBITDA was -$30.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 26.0% from the prior year.

Net Income
-$25
YoY+49.6%

Xos Inc reported -$25 in net income in fiscal year 2025. This represents an increase of 49.6% from the prior year.

EPS (Diluted)
$-2.71
YoY+59.5%

Xos Inc earned $-2.71 per diluted share (EPS) in fiscal year 2025. This represents an increase of 59.5% from the prior year.

Cash & Balance Sheet

Free Cash Flow
$5.4M
YoY+111.0%

Xos Inc generated $5.4M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 111.0% from the prior year.

Cash & Debt
$14.0M
YoY+27.7%
5Y CAGR+6.3%

Xos Inc held $14.0M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
11M
YoY+41.7%
5Y CAGR-30.9%

Xos Inc had 11M shares outstanding in fiscal year 2025. This represents an increase of 41.7% from the prior year.

Margins & Returns

Gross Margin
5.9%
YoY-1.2pp
5Y CAGR-5.4pp

Xos Inc's gross margin was 5.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 1.2 percentage points from the prior year.

Operating Margin
-71.9%
YoY+10.0pp
5Y CAGR+377.6pp

Xos Inc's operating margin was -71.9% in fiscal year 2025, reflecting core business profitability. This is up 10.0 percentage points from the prior year.

Net Margin
0.0%
YoY+0.0pp
5Y CAGR+631.1pp

Xos Inc's net profit margin was 0.0% in fiscal year 2025, showing the share of revenue converted to profit. This is up 0.0 percentage points from the prior year.

Return on Equity
0.0%
YoY+0.0pp

Xos Inc's ROE was 0.0% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 0.0 percentage points from the prior year.

Capital Allocation

R&D Spending
$8.0M
YoY-24.7%
5Y CAGR+2.7%

Xos Inc invested $8.0M in research and development in fiscal year 2025. This represents a decrease of 24.7% from the prior year.

Share Buybacks
N/A
Capital Expenditures
$0
YoY-100.0%

Xos Inc invested $0 in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 100.0% from the prior year.

XOSWW Income Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Revenue $11.2M+115.0% $5.2M-68.4% $16.5M-10.3% $18.4M+212.9% $5.9M-48.8% $11.5M-27.3% $15.8M+1.6% $15.5M
Cost of Revenue $6.9M-12.3% $7.9M-43.8% $14.0M-16.7% $16.8M+259.3% $4.7M-69.3% $15.2M+17.5% $12.9M-4.3% $13.5M
Gross Profit $4.3M+264.4% -$2.6M-204.2% $2.5M+56.3% $1.6M+33.7% $1.2M+132.6% -$3.7M-229.8% $2.9M+41.1% $2.0M
R&D Expenses $2.0M+7.9% $1.9M-10.4% $2.1M+0.7% $2.1M+8.1% $1.9M-0.3% $1.9M-26.1% $2.6M-12.6% $3.0M
SG&A Expenses $6.1M+33.6% $4.5M-29.7% $6.5M+9.3% $5.9M-25.2% $7.9M-1.9% $8.1M-9.5% $8.9M-3.0% $9.2M
Operating Income -$4.7M+52.0% -$9.7M-39.2% -$7.0M+1.2% -$7.1M+23.6% -$9.3M+36.4% -$14.6M-50.4% -$9.7M+14.8% -$11.4M
Interest Expense N/A N/A N/A N/A N/A N/A N/A N/A
Income Tax $5K $0+100.0% -$2K-115.4% $13K+8.3% $12K-50.0% $24K+500.0% $4K0.0% $4K
Net Income -$5.0M-131.8% $15.6M+633.3% $2.1M+128.3% -$7.5M+26.3% -$10.2M-132.7% $31.2M+396.6% -$10.5M-8.8% -$9.7M
EPS (Diluted) $-0.43 N/A $0.22+124.2% $-0.91+27.8% $-1.26 N/A $-1.32-7.3% $-1.23

XOSWW Balance Sheet

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Total Assets $54.4M-9.9% $60.4M-18.2% $73.8M-8.1% $80.3M-8.4% $87.7M-10.8% $98.3M-18.4% $120.5M-2.4% $123.4M
Current Assets $45.3M-9.2% $49.9M-20.2% $62.5M-6.2% $66.6M-8.8% $73.1M-11.2% $82.3M-15.7% $97.6M-2.5% $100.1M
Cash & Equivalents $9.8M-29.9% $14.0M-0.2% $14.1M+60.1% $8.8M+84.6% $4.8M-56.7% $11.0M+30.4% $8.4M-57.1% $19.7M
Inventory $23.7M-5.2% $25.0M-1.0% $25.2M-18.7% $31.0M-18.4% $38.0M+3.9% $36.6M-13.8% $42.4M+2.5% $41.4M
Accounts Receivable $7.4M+22.6% $6.0M-60.7% $15.4M-15.0% $18.1M-18.6% $22.2M-17.3% $26.9M-26.3% $36.4M+22.5% $29.7M
Goodwill N/A N/A N/A N/A N/A N/A N/A N/A
Total Liabilities $34.6M-6.6% $37.1M-13.3% $42.8M-31.1% $62.0M-1.4% $62.9M-2.9% $64.7M-7.1% $69.7M+8.5% $64.2M
Current Liabilities $23.9M+1.2% $23.7M-8.9% $26.0M-13.7% $30.1M-33.7% $45.4M-2.8% $46.7M-7.0% $50.2M+150.3% $20.1M
Long-Term Debt N/A N/A N/A N/A N/A N/A N/A N/A
Total Equity $19.8M-15.0% $23.3M-25.0% $31.1M+69.5% $18.3M-26.1% $24.8M-26.2% $33.6M-33.9% $50.8M-14.2% $59.2M
Retained Earnings -$233.7M-2.2% -$228.7M-4.5% -$219.0M+1.0% -$221.1M-3.5% -$213.6M-5.0% -$203.4M-10.3% -$184.4M-6.0% -$173.9M

XOSWW Cash Flow Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Operating Cash Flow -$1.6M-165.2% $2.4M-20.9% $3.1M-33.8% $4.6M+197.7% -$4.8M-244.2% $3.3M+128.6% -$11.5M+55.7% -$26.0M
Capital Expenditures $19K $0 $0 $0 $0 $0-100.0% $148K+17.5% $126K
Free Cash Flow -$1.6M-166.0% $2.4M-20.9% $3.1M-33.8% $4.6M+197.7% -$4.8M-244.2% $3.3M+128.3% -$11.7M+55.3% -$26.1M
Investing Cash Flow $312K+1633.3% $18K-58.1% $43K $0 $0 $0+100.0% -$23K+81.7% -$126K
Financing Cash Flow -$2.9M-19.3% -$2.4M-213.0% $2.2M+449.7% -$618K+58.3% -$1.5M+0.4% -$1.5M-3820.0% $40K+108.3% -$484K
Dividends Paid N/A N/A N/A N/A N/A N/A N/A N/A
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

XOSWW Financial Ratios

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Gross Margin 38.6%+89.1pp -50.5%-65.9pp 15.3%+6.5pp 8.8%-11.8pp 20.6%+53.0pp -32.4%-50.5pp 18.1%+5.1pp 13.1%
Operating Margin -41.7%+144.9pp -186.6%-144.2pp -42.4%-3.9pp -38.5%+119.2pp -157.7%-30.7pp -127.0%-65.6pp -61.4%+11.8pp -73.2%
Net Margin -44.1%-342.4pp 298.2%+285.4pp 12.9%+53.7pp -40.8%+132.5pp -173.3%-445.0pp 271.7%+338.3pp -66.6%-4.4pp -62.2%
Return on Equity -25.0%-91.9pp 66.8%+60.0pp 6.8%+47.8pp -40.9%+0.1pp -41.1%-133.8pp 92.8%+113.4pp -20.7%-4.4pp -16.3%
Return on Assets -9.1%-34.9pp 25.8%+22.9pp 2.9%+12.2pp -9.3%+2.3pp -11.6%-43.3pp 31.7%+40.4pp -8.7%-0.9pp -7.8%
Current Ratio 1.89-0.2 2.11-0.3 2.41+0.2 2.22+0.6 1.61-0.2 1.76-0.2 1.94-3.0 4.99
Debt-to-Equity 1.75+0.2 1.59+0.2 1.38-2.0 3.38+0.8 2.53+0.6 1.93+0.6 1.37+0.3 1.08
FCF Margin -14.3%-60.9pp 46.6%+28.0pp 18.6%-6.6pp 25.3%+106.2pp -80.9%-109.6pp 28.7%+102.6pp -73.9%+94.2pp -168.1%

Frequently Asked Questions

Xos Inc (XOSWW) reported $46.0M in total revenue for fiscal year 2025. This represents a -17.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Xos Inc (XOSWW) revenue declined by 17.8% year-over-year, from $56.0M to $46.0M in fiscal year 2025.

No, Xos Inc (XOSWW) reported a net income of -$25 in fiscal year 2025, with a net profit margin of 0.0%.

Xos Inc (XOSWW) reported diluted earnings per share of $-2.71 for fiscal year 2025. This represents a 59.5% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Xos Inc (XOSWW) had EBITDA of -$30.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Xos Inc (XOSWW) had a gross margin of 5.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Xos Inc (XOSWW) had an operating margin of -71.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Xos Inc (XOSWW) had a net profit margin of 0.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Xos Inc (XOSWW) has a return on equity of 0.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Xos Inc (XOSWW) generated $5.4M in free cash flow during fiscal year 2025. This represents a 111.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Xos Inc (XOSWW) generated $5.4M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Xos Inc (XOSWW) had $60.4M in total assets as of fiscal year 2025, including both current and long-term assets.

Xos Inc (XOSWW) invested $0 in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Xos Inc (XOSWW) invested $8.0M in research and development during fiscal year 2025.

Xos Inc (XOSWW) had 11M shares outstanding as of fiscal year 2025.

Xos Inc (XOSWW) had a current ratio of 2.11 as of fiscal year 2025, which is generally considered healthy.

Xos Inc (XOSWW) had a debt-to-equity ratio of 1.59 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Xos Inc (XOSWW) had a return on assets of 0.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Xos Inc (XOSWW) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Xos Inc (XOSWW) has an earnings quality ratio of -213438.74x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Xos Inc (XOSWW) scores 24 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.

Back to top